Sheila Lindsay

849 total citations
19 papers, 569 citations indexed

About

Sheila Lindsay is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Sheila Lindsay has authored 19 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Epidemiology. Recurrent topics in Sheila Lindsay's work include Neuroendocrine Tumor Research Advances (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and Neuroblastoma Research and Treatments (4 papers). Sheila Lindsay is often cited by papers focused on Neuroendocrine Tumor Research Advances (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and Neuroblastoma Research and Treatments (4 papers). Sheila Lindsay collaborates with scholars based in United States. Sheila Lindsay's co-authors include Electron Kebebew, Orlo H. Clark, Francis S. Greenspan, Kenneth A. Woeber, Leon Goldman, Michael E. Dailey, Thomas A. Hope, W. S. Graham, Jonathan Strosberg and Amanda Abbott and has published in prestigious journals such as Journal of Clinical Oncology, The Oncologist and Journal of Nuclear Medicine.

In The Last Decade

Sheila Lindsay

19 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheila Lindsay United States 12 296 189 136 117 88 19 569
G. F. W. Scheumann Germany 11 285 1.0× 152 0.8× 126 0.9× 189 1.6× 205 2.3× 25 591
M Arganini Italy 12 437 1.5× 171 0.9× 99 0.7× 300 2.6× 40 0.5× 28 650
Frank J. Quayle United States 9 230 0.8× 119 0.6× 163 1.2× 215 1.8× 25 0.3× 9 423
Th. P. Links Netherlands 8 342 1.2× 139 0.7× 158 1.2× 97 0.8× 60 0.7× 13 437
Fabiana Pani Italy 14 212 0.7× 161 0.9× 93 0.7× 67 0.6× 66 0.8× 28 446
S Garancini Italy 12 118 0.4× 227 1.2× 294 2.2× 112 1.0× 47 0.5× 20 570
Jean‐Claude Bigorgne France 8 745 2.5× 102 0.5× 255 1.9× 378 3.2× 96 1.1× 10 826
Roxanne Merkel United States 12 119 0.4× 217 1.1× 173 1.3× 100 0.9× 70 0.8× 16 459
P Fragu France 9 475 1.6× 119 0.6× 103 0.8× 204 1.7× 57 0.6× 17 613
Šárka Dvořáková Czechia 12 389 1.3× 141 0.7× 93 0.7× 176 1.5× 119 1.4× 21 527

Countries citing papers authored by Sheila Lindsay

Since Specialization
Citations

This map shows the geographic impact of Sheila Lindsay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Lindsay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Lindsay more than expected).

Fields of papers citing papers by Sheila Lindsay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila Lindsay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Lindsay. The network helps show where Sheila Lindsay may publish in the future.

Co-authorship network of co-authors of Sheila Lindsay

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Lindsay. A scholar is included among the top collaborators of Sheila Lindsay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Lindsay. Sheila Lindsay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Stephanie J., Nancy M. Joseph, Sheila Lindsay, et al.. (2025). Factors associated with grade progression in pancreatic neuroendocrine tumors. Endocrine Related Cancer. 32(3). 2 indexed citations
2.
Masharani, Umesh, et al.. (2024). Metastatic insulinoma—outcomes in the current era. The Oncologist. 30(3). 1 indexed citations
3.
Lindsay, Sheila, et al.. (2024). Withdrawal pain following patients discontinuing Trk inhibitors. Journal of Oncology Pharmacy Practice. 31(1). 147–150. 2 indexed citations
4.
Lawhn-Heath, Courtney, et al.. (2024). The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy. Journal of Nuclear Medicine. 65(3). 409–415. 5 indexed citations
5.
Bocobo, Andrea Grace, Spencer C. Behr, Julia Carnevale, et al.. (2021). Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Interim analysis.. Journal of Clinical Oncology. 39(3_suppl). 77–77. 13 indexed citations
6.
Lawhn-Heath, Courtney, Nicholas Fidelman, Salma Jivan, et al.. (2020). Intraarterial Peptide Receptor Radionuclide Therapy Using90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors. Journal of Nuclear Medicine. 62(2). 221–227. 15 indexed citations
7.
Hope, Thomas A., Amanda Abbott, David Bushnell, et al.. (2019). NANETS/SNMMI Procedure Standard for Somatostatin Receptor–Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. Journal of Nuclear Medicine. 60(7). 937–943. 108 indexed citations
8.
Guerrero, Marlon A., Sheila Lindsay, Insoo Suh, et al.. (2011). Medullary Thyroid Cancer: It is a pain in the neck?. Journal of Cancer. 2. 200–205. 5 indexed citations
9.
Elaraj, Dina M., Rebecca S. Sippel, Sheila Lindsay, et al.. (2009). 11. Prospective Validation of a Simple Scoring Model to Predict Single Gland Disease in Patients With Primary Hyperparathyroidism (PHPT). Journal of Surgical Research. 151(2). 177–177. 1 indexed citations
10.
Kebebew, Electron, Sheila Lindsay, Orlo H. Clark, et al.. (2009). Results of Rosiglitazone Therapy in Patients with Thyroglobulin-Positive and Radioiodine-Negative Advanced Differentiated Thyroid Cancer. Thyroid. 19(9). 953–956. 61 indexed citations
11.
Sippel, Rebecca S., Dina M. Elaraj, Electron Kebebew, et al.. (2008). Waiting for change: Symptom resolution after adrenalectomy for Cushing's syndrome. Surgery. 144(6). 1054–1061. 44 indexed citations
12.
Kebebew, Electron, Miao Peng, Emily Reiff, et al.. (2006). A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer. Surgery. 140(6). 960–967. 91 indexed citations
13.
Lindsay, Sheila, et al.. (1968). Carcinogenic effect of irradiation. Low doses of radioactive iodine on the thyroid gland of the rat and mouse.. PubMed. 85(5). 487–92. 11 indexed citations
14.
Lindsay, Sheila, et al.. (1965). THE RELATION OF THYROID CARCINOMA AND CHRONIC THYROIDITIS.. PubMed. 121. 243–52. 92 indexed citations
15.
Lindsay, Sheila, et al.. (1963). Comparison of the incidence of complications following total and subtotal thyroidectomy for thyroid carcinoma.. PubMed. 116. 109–12. 20 indexed citations
16.
Goldman, Leon, et al.. (1962). Thyroid carcinoma in patients with hyperparathyroidism.. PubMed. 51. 708–17. 60 indexed citations
17.
Lindsay, Sheila. (1960). Natural history of thyroid carcinoma.. PubMed. 17. 623–7. 7 indexed citations
18.
Potter, G. D., Sheila Lindsay, & I.L. Chaikoff. (1960). Induction of neoplasms in rat thyroid glands by low doses of radio-iodine.. PubMed. 69. 257–69. 20 indexed citations
19.
Lindsay, Sheila & Michael E. Dailey. (1954). Granulomatous or giant cell thyroiditis; a clinical and pathologic study of thirty-seven patients.. PubMed. 98(2). 197–212. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026